Salud financiera de hoja de balance de VIA Labs

Salud financiera controles de criterios 6/6

VIA Labs tiene un patrimonio de accionistas total de NT$2.9B y una deuda total de NT$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son NT$3.7B y NT$839.6M respectivamente. El BAIT de VIA Labs es de NT$117.5M, por lo que su ratio de cobertura de intereses es de -2.3. Tiene efectivo e inversiones a corto plazo que ascienden a NT$1.8B.

Información clave

Ratio deuda-patrimonio

NT$0

Deuda

Ratio de cobertura de intereses	-2.3x
Efectivo	NT$1.77b
Patrimonio	NT$2.87b
Total pasivo	NT$839.58m
Activos totales	NT$3.71b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 15

We Think You Can Look Beyond VIA Labs' (TWSE:6756) Lackluster Earnings

Mar 21

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 11

Is Weakness In VIA Labs, Inc. (TPE:6756) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 03

Should VIA Labs, Inc. (TPE:6756) Be Part Of Your Dividend Portfolio?

Jan 12

We Like VIA Labs' (GTSM:6756) Returns And Here's How They're Trending

Dec 17

Getting In Cheap On VIA Labs, Inc. (GTSM:6756) Might Be Difficult

Nov 25

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$2.2B) de 6756 superan a sus pasivos a corto plazo (NT$717.5M).

Pasivo a largo plazo: Los activos a corto plazo de 6756 (NT$2.2B) superan a sus pasivos a largo plazo (NT$32.6M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 6756 está libre de deudas.

Reducción de la deuda: 6756 no tenía deudas hace 5 años.

Cobertura de la deuda: 6756 no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: 6756 no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Salud financiera de hoja de balance de VIA Labs

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

First quarter 2024 earnings released: EPS: NT$0.73 (vs NT$0.22 in 1Q 2023)

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Upcoming dividend of NT$2.00 per share

We Think You Can Look Beyond VIA Labs' (TWSE:6756) Lackluster Earnings

Full year 2023 earnings released: EPS: NT$2.62 (vs NT$10.57 in FY 2022)

VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year

Dividend of NT$2.00 announced

Investor sentiment deteriorates as stock falls 16%

VIA Labs, Inc., Annual General Meeting, Jun 20, 2024

New major risk - Revenue size

New minor risk - Share price stability

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: NT$1.15 (vs NT$3.73 in 2Q 2022)

Upcoming dividend of NT$7.49 per share at 3.2% yield

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Third quarter 2022 earnings released: EPS: NT$2.01 (vs NT$3.56 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: NT$4.23 (vs NT$2.74 in 1Q 2021)

Price target increased to NT$510

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$10.99 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$3.56 (vs NT$1.30 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS NT$3.08 (vs NT$1.37 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS NT$2.74 (vs NT$1.31 in 1Q 2020)

Upcoming dividend of NT$4.50 per share

Robust Earnings May Not Tell The Whole Story For VIA Labs (TPE:6756)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$5.29 (vs NT$4.05 in FY 2019)

VIA Labs (TPE:6756) Is Achieving High Returns On Its Capital

Should VIA Labs (TPE:6756) Be Disappointed With Their 84% Profit?

Is Weakness In VIA Labs, Inc. (TPE:6756) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Should VIA Labs, Inc. (TPE:6756) Be Part Of Your Dividend Portfolio?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

We Like VIA Labs' (GTSM:6756) Returns And Here's How They're Trending

New 90-day low: NT$298

Getting In Cheap On VIA Labs, Inc. (GTSM:6756) Might Be Difficult

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera